Literature DB >> 28461494

Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.

Shannon R Hinson1, Ian C Clift1, Ningling Luo1, Thomas J Kryzer1, Vanda A Lennon2,3,4.   

Abstract

Aquaporin-4 (AQP4) water channel-specific IgG distinguishes neuromyelitis optica (NMO) from multiple sclerosis and causes characteristic immunopathology in which central nervous system (CNS) demyelination is secondary. Early events initiating the pathophysiological outcomes of IgG binding to astrocytic AQP4 are poorly understood. CNS lesions reflect events documented in vitro following IgG interaction with AQP4: AQP4 internalization, attenuated glutamate uptake, intramyelinic edema, interleukin-6 release, complement activation, inflammatory cell recruitment, and demyelination. Here, we demonstrate that AQP4 internalization requires AQP4-bound IgG to engage an astrocytic Fcγ receptor (FcγR). IgG-lacking Fc redistributes AQP4 within the plasma membrane and induces interleukin-6 release. However, AQP4 endocytosis requires an activating FcγR's gamma subunit and involves astrocytic membrane loss of an inhibitory FcγR, CD32B. Interaction of the IgG-AQP4 complex with FcγRs triggers coendocytosis of the excitatory amino acid transporter 2 (EAAT2). Requirement of FcγR engagement for internalization of two astrocytic membrane proteins critical to CNS homeostasis identifies a complement-independent, upstream target for potential early therapeutic intervention in NMO.

Entities:  

Keywords:  CD32; CD64; autoimmune astrocytopathy; neuromyelitis optica; pathogenic IgG

Mesh:

Substances:

Year:  2017        PMID: 28461494      PMCID: PMC5448211          DOI: 10.1073/pnas.1701960114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement.

Authors:  Hiroyo Haruki; Yasuteru Sano; Fumitaka Shimizu; Masatoshi Omoto; Ayako Tasaki; Mariko Oishi; Michiaki Koga; Kazuyuki Saito; Toshiyuki Takahashi; Tsutomu Nakada; Takashi Kanda
Journal:  J Neurol Sci       Date:  2013-06-25       Impact factor: 3.181

2.  Alpah-adrenergic receptor modulation of beta-adrenergic, adenosine and prostaglandin E1 increased adenosine 3':5'-cyclic monophosphate levels in primary cultures of glia.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cyclic Nucleotide Res       Date:  1978-02

3.  Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.

Authors:  Romain Marignier; Pascale Giraudon; Sandra Vukusic; Christian Confavreux; Jérôme Honnorat
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

4.  Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.

Authors:  Shannon R Hinson; Michael F Romero; Bogdan F Gh Popescu; Claudia F Lucchinetti; James P Fryer; Hartwig Wolburg; Petra Fallier-Becker; Susan Noell; Vanda A Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-29       Impact factor: 11.205

5.  Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

Authors:  C Papeix; J-S Vidal; J de Seze; C Pierrot-Deseilligny; A Tourbah; B Stankoff; C Lebrun; T Moreau; P Vermersch; B Fontaine; O Lyon-Caen; O Gout
Journal:  Mult Scler       Date:  2007-01-29       Impact factor: 6.312

6.  Tyrosine phosphorylation provides an obligatory early signal for Fc gamma RII-mediated endocytosis in the monocytic cell line THP-1.

Authors:  S Ghazizadeh; H B Fleit
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

7.  Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.

Authors:  Charles L Howe; Tatiana Kaptzan; Setty M Magaña; Jennifer R Ayers-Ringler; Reghann G LaFrance-Corey; Claudia F Lucchinetti
Journal:  Glia       Date:  2014-02-03       Impact factor: 7.452

Review 8.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

9.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

10.  NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.

Authors:  Margaret E Walker-Caulfield; Yong Guo; Renee K Johnson; Christina B McCarthy; Patrick D Fitz-Gibbon; Claudia F Lucchinetti; Charles L Howe
Journal:  J Neuroinflammation       Date:  2015-09-30       Impact factor: 8.322

View more
  16 in total

Review 1.  Chansporter complexes in cell signaling.

Authors:  Geoffrey W Abbott
Journal:  FEBS Lett       Date:  2017-08-02       Impact factor: 4.124

Review 2.  Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Authors:  Jayne L Chamberlain; Saif Huda; Daniel H Whittam; Marcelo Matiello; B Paul Morgan; Anu Jacob
Journal:  J Neurol       Date:  2019-09-03       Impact factor: 4.849

3.  Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion.

Authors:  Tingjun Chen; Vanda A Lennon; Yong U Liu; Dale B Bosco; Yujiao Li; Min-Hee Yi; Jia Zhu; Shihui Wei; Long-Jun Wu
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 4.  The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment.

Authors:  Simone Mader; Lior Brimberg; Betty Diamond
Journal:  Front Immunol       Date:  2017-09-11       Impact factor: 7.561

5.  Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice.

Authors:  Leung-Wah Yick; Oscar Ka-Fai Ma; Roy Chun-Laam Ng; Jason Shing-Cheong Kwan; Koon-Ho Chan
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

6.  The Demonstration of an Aqp4/Tgf-beta 1 Pathway in Murine Astrocytes Holds Implications for Both Neuromyelitis Optica and Progressive Multiple Sclerosis.

Authors:  Serge Nataf
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

Review 7.  Role of B Cells in Multiple Sclerosis and Related Disorders.

Authors:  Giancarlo Comi; Amit Bar-Or; Hans Lassmann; Antonio Uccelli; Hans-Peter Hartung; Xavier Montalban; Per Solberg Sørensen; Reinhard Hohlfeld; Stephen L Hauser
Journal:  Ann Neurol       Date:  2020-11-04       Impact factor: 10.422

Review 8.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26

Review 9.  Epidemiology of neuromyelitis optica in Latin America.

Authors:  M P Alvarenga; Sergio Schimidt; Rm Papais Alvarenga
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25

10.  Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.

Authors:  Leung-Wah Yick; Chi-Ho Tang; Oscar Ka-Fai Ma; Jason Shing-Cheong Kwan; Koon-Ho Chan
Journal:  J Neuroinflammation       Date:  2020-08-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.